Delivery Order SPE2DB24D1205-SPE2DB25FCWJX

Award Date 5/2/25
Potential Completion Date 5/23/25
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $10,662.57, is for the delivery of Tagrisso 80 mg tablets, a medication used in cancer treatment. The contract has a firm fixed price and an ultimate completion date of February 4, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distributor. The contract is for the delivery of Tagrisso 80 mg tablets, a specialty pharmaceutical product. The award has a ceiling value of $21,077.60 and a completion date of April 12, 2024. No set-aside designation was used. AmerisourceBergen Drug Corp also holds an...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,662.57 firm fixed-price delivery order is for the supply of Tagrisso 80 mg tablets, a medication used to treat a specific type of lung cancer. The contract has an ultimate completion date of May 6, 2025 and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the prescription medication Tagrisso 80 mg tablet in 30-count packages, with a total ceiling value of $10,662.57. The contract is a firm fixed-price, non-set-aside award with a performance period ending on May 13, 2025. AmerisourceBergen Drug Corp holds a significant...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $10,538.79 to Amerisourcebergen Drug Corporation for the supply of Tagrisso 80 mg tablets. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, worth up to $999,999,999.00 through December 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical products and medical supplies, including specialty,...
This is a $10,538.79 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the medical product "TAGRISSO 80 MG TABLET 30S" and has an ultimate completion date of July 25, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $10,662.57 contract is for the delivery of TAGRISSO 80 MG TABLET 30S, a prescription medication, with a performance period ending on May 23, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the medication Tagrisso 80 mg tablet, with a ceiling value of $10,662.57 and a period of performance through May 9, 2025. This is a delivery order contract with a firm fixed price pricing type. The contract is not set aside and is open to full and open competition. Amerisourcebergen...
This is a $10,508.31 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for TAGRISSO 40 MG TABLET 30S, a medication, and has a completion date of July 19, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and federal contractor. The contract, valued at $31,585.91, is for the supply of Tagrisso 80 mg tablets. This is a firm fixed price contract with an ultimate completion date of October 16, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp, as the prime contractor, will be responsible for delivering...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB25FCWJX
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Tagrisso 80 mg tablets, a medication used to treat non-small cell lung cancer. The contract has a ceiling value of $10,662.57 and an ultimate completion date of May 23, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order is likely part of the company's broader contract to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs.

Generated 8/3/25, 1:06 AM